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LETTERS TO THE EDITOR
Effect of obesity on PD versus
HD survival: Is caloric intake
the discriminating factor?
To the Editor: Higher body mass index (BMI) and its
positive association with dialysis patients’ survival has be-
come an area of interest [1]. Abbott et al [2] have recently
published an article suggesting that any paradoxical sur-
vival advantage observed with obesity in hemodialysis
(HD) patients may not be seen in patients on peritoneal
dialysis (PD). This contradicts an earlier report by Sny-
der et al [3], but Abbott et al’s finding is probably more
reflective of the long-term. If the finding by Abbott et al
is to be confirmed (i.e., obesity in PD is not associated
with any long-term survival advantage), then one has to
ask the interesting question as to why there may be a
“paradox within paradox?”
We would like to propose an intriguing and plausible
hypothesis that involves difference in the caloric intake.
In general, all PD patients, obese or nonobese, employ
1.5% to 4.25% of dextrose in their dialysate, often around
the clock, that is estimated to be absorbed at 45% [4]. In
contrast, HD patients are exposed to 1% of dextrose in
their dialysate during the 4-hour, thrice weekly dialysis.
Therefore, the higher caloric intake, rather than obesity,
per se, may account for the better survival of dialysis pa-
tients, and this may help to explain why nonobese patients
on PD may not display any less survival advantage com-
pared with their obese counterparts (Fig. 1). A higher
caloric intake by dialysis patients for many conceivable
reasons may contribute to longer survival. Anyone for a
controlled trial?
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Fig. 1. Hypothesis that caloric intake (dotted arrows) rather than body
composition (large circle represents the obese, small circle represents
the lean) dictates survival on dialysis. In spite of potentially reduced oral
caloric intake by the underweight peritoneal dialysis (PD) patients, the
dextrose in the PD dialysate ensures a minimum “high” caloric intake,
theoretically accounting for a survival no less than the obese PD pa-
tients. Lack of caloric compensation among the underweight hemodial-
ysis patients may explain a reduced survival rate.
On the epithelial-mesenchymal
transition of mesothelial cells
To the Editor: In a recently published review article,
Williams et al [1], on behalf of the Biopsy Registry Study
Group, to which some of us belong, raise several criticisms
regarding the paper published by our group in the New
England Journal of Medicine [2] without first consulting
us or taking into account our opinion. In general, these
comments are not scientifically based and appear to be
personal opinions.
Williams et al remarked only on our data regarding
the down-regulation of cytokeratin expression and the
increase in vimentin expression by effluent mesothelial
cells when compared to “in situ” cells, sentencing that
these markers are modulated by the simple “ex vivo”
culture of mesothelial cells, questioning the epithelial-
mesenchymal transition phenomenon itself. With this
simplistic point of view, the authors left out additional
and much more important markers, which confirmed
the epithelial-mesenchymal transition in our study (i.e.,
down-regulation of E-cadherin, induction of snail nuclear
factor, and changes in integrin expression).
Furthermore, they affirm to be “unable to identify
in vivo similar fibroblastic phenotypic changes in the
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mesothelial cells,” but, to our knowledge, these authors
never employed immunohistochemical analysis in any of
their published papers on peritoneal biopsy morphology.
Immunohistochemistry is absolutely necessary to distin-
guish the different fibroblastic subpopulations in the peri-
toneal tissue before and during peritoneal dialysis (PD).
In a recent and ulterior study [3], we have further con-
firmed the existence of a fibroblast subpopulation derived
from the mesothelium in patients undergoing PD.
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Reply from the Authors
Dr. Selgas and his colleagues suggest in their letter that
our recently published review [1] was unreasonably criti-
cal of their paper in the New England Journal of Medicine
[2] and was based on personal rather than scientific opin-
ion. In fact, our review was fully referenced, including
the statements used in the critique of Dr. Selgas’ paper.
We believe that there is data available in the scientific
literature that they have chosen not to consider, and we
indicated this in our publication. Furthermore, we indi-
cated that their presentation of peritoneal morphology is
in contrast to that with which we are familiar.
With regard to our relationship to the Peritoneal
Biopsy Registry, we wish to make it clear that the opin-
ions expressed in the review are solely those of the named
authors. We do acknowledge the donation of peritoneal
tissue by all the centers listed at the end of our review,
and we apologize for any confusion caused. The opin-
ions of the authors are based on the experience gained
by examination of this collection of biopsies.
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A catalog of gene expression in
the developing kidney
To the Editor: In a recent paper, Schwab et al [1] pro-
vided an extensive description of gene expression dur-
ing mouse nephrogenesis by coupling microarrays and
robust target microamplification techniques. In addition
to other evidences of kidney stepwise organogenesis in
the rat [2], this work established very useful baselines
for further investigations of mouse nephrogenesis. How-
ever, one should emphasize that gene regulation only rep-
resents the first step of tissue differentiation that should
be complemented by studies at the protein level. We have
recently described ontogeny patterns of proximal tubule
(PT) transporters during mouse and human nephrogene-
sis, showing that PT maturation was essentially achieved
at the initiation of glomerular filtration [3]. The compar-
ison of data obtained by real-time polymerase chain re-
action (PCR) and immunoblotting in mouse embryonic
kidneys clearly shows that divergent ontogeny pat-
terns can be observed at the mRNA and protein lev-
els (Fig. 1). Additional differences may also arise from
post-translational modifications, such as complex N-
glycosylation, which may also be regulated during on-
togeny and plays a significant role in protein maturation
[3]. In conclusion, gene expression analyses represent a
powerful tool to identify and compare pathways involved
in regular and mutant embryogenesis [4]. However, the
complexity of post-transcriptional regulations should be
considered when integrating the factors involved in dif-
ferentiation and organogenesis cascades.
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